According to SEC filings for the period ending December 2025, 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) is held by 92 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 4,302,905 | 174,489 | 4.23% | $32,271,789.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 4,064,876 | 195,746 | 5.06% | $30,486,573.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 3,093,527 | 518,405 | 20.13% | $23,201,453.00 |
| STATE STREET CORP | 31 Dec, 2025 | 2,688,880 | 1,785,106 | 197.52% | $20,166,600.00 |
| FEDERATED HERMES, INC. | 31 Dec, 2025 | 1,609,482 | 14,650 | 0.92% | $12,071,116.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 1,012,025 | 98,506 | 10.78% | $7,591,665.00 |
| DEUTSCHE BANK AG\ | 31 Dec, 2025 | 704,207 | 160,876 | 29.61% | $5,281,553.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 672,695 | -163,216 | -19.53% | $5,045,215.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 512,900 | 199,714 | 63.77% | $3,846,750.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 353,391 | 47,534 | 15.54% | $2,650,433.00 |
| Assenagon Asset Management S.A. | 31 Dec, 2025 | 296,199 | -367,458 | -55.37% | $2,221,493.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 294,841 | 236,835 | 408.29% | $2,211,439.00 |
| JPMORGAN CHASE & CO | 31 Dec, 2025 | 279,505 | -234,010 | -45.57% | $2,096,289.00 |
| Peapod Lane Capital LLC | 31 Dec, 2025 | 268,024 | -54,057 | -16.78% | $2,010,180.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 241,103 | 99,688 | 70.49% | $1,808,272.00 |
| UBS Group AG | 31 Dec, 2025 | 231,292 | 136,392 | 143.72% | $1,734,690.00 |
| Privium Fund Management B.V. | 31 Dec, 2025 | 210,000 | 12,542 | 6.35% | $1,575,000.00 |
| BARCLAYS PLC | 31 Dec, 2025 | 170,639 | 76,811 | 81.86% | $1,279,793.00 |
| Nuveen, LLC | 31 Dec, 2025 | 158,769 | 64,850 | 69.05% | $1,190,768.00 |
| Perigon Wealth Management, LLC | 31 Dec, 2025 | 146,133 | 0 | 0.00% | $1,095,998.00 |